[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.159.27. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 144
Citations 0
Comment & Response
November 2015

The Lariat for Left Atrial Appendage Closure: Rehash of Known Literature or a True Analysis?

Author Affiliations
  • 1Division of Cardiovascular Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore
JAMA Intern Med. 2015;175(11):1868-1869. doi:10.1001/jamainternmed.2015.5399

To the Editor In their systematic review of the Lariat (SentreHeart Inc) left atrial appendage (LAA) ligation system, Chatterjee et al1 question the safety classification of the device, citing adverse events recorded in the US Food and Drug Administration’s (FDA) Manufacturer and User Facility Device Experience (MAUDE) database.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×